Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Methods in Enzymology|December 24, 2013
Liposome-based assays to study membrane-associated protein networksChristian Niehage, Christoph Stange, Mihaela Anitei, et al.Molecular Membrane Biology|November 9, 2010
Bidirectional transport between the trans-Golgi network and the endosomal systemMihaela Anitei, Thomas Wassmer, Christoph Stange, et al.Plos One|November 8, 2014
Septin6 and Septin7 GTP binding proteins regulate AP-3- and ESCRT-dependent multivesicular body biogenesisSofia Traikov, Christoph Stange, Thomas Wassmer, et al.Nature Cell Biology|March 16, 2010
Protein complexes containing CYFIP/Sra/PIR121 coordinate Arf1 and Rac1 signalling during clathrin-AP-1-coated carrier biogenesis at the TGNMihaela Anitei, Christoph Stange, Irina Parshina, et al.British Journal of Cancer|June 27, 2025
PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancerChristoph Stange, Tobias F Dreyer, Maximilian Riedel, et al.Cell Reports|August 31, 2017
Spatiotemporal Control of Lipid Conversion, Actin-Based Mechanical Forces, and Curvature Sensors during Clathrin/AP-1-Coated Vesicle BiogenesisMihaela Anitei, Christoph Stange, Cornelia Czupalla, et al.British Journal of Cancer|March 22, 2022
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.Biomolecules|May 28, 2025
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer TreatmentMaria-Veronica Teleanu, Annika Schneider, Claudia R Ball, et al.Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.Cancer Immunology Research|April 28, 2021
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In VivoTobias F Dreyer, Sabine Kuhn, Christoph Stange, et al.Pageof 1